erlotinib hydrochloride has been researched along with Abnormalities, Autosome in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimoto-Ouchi, K; Furugaki, K; Harada, N; Iwai, T; Moriya, Y | 1 |
| Koh, Y; Serizawa, M; Takahashi, T; Yamamoto, N | 1 |
| Fischer, F; Frommolt, P; Garraway, LA; Gazdar, AF; Girard, L; Heynck, S; Kashkar, H; Koker, M; Mermel, C; Meyerson, M; Michel, K; Minna, JD; Pao, W; Peifer, M; Peyton, M; Rabinovsky, R; Seeger, JM; Sos, ML; Thomas, RK; Weir, BA; Weiss, J; Zander, T | 1 |
| Chandra, NR; Efferth, T; Gebhart, E; Konkimalla, VB; Suhas, VL | 1 |
1 review(s) available for erlotinib hydrochloride and Abnormalities, Autosome
| Article | Year |
|---|---|
Diagnosis and therapy of oral squamous cell carcinoma.
Topics: Age Factors; Alcohol Drinking; Antineoplastic Agents; Aporphines; Azo Compounds; Berberine; Carcinoma, Squamous Cell; Chromosome Aberrations; Crystallography, X-Ray; Databases, Factual; DNA, Neoplasm; Drug Screening Assays, Antitumor; Drugs, Chinese Herbal; ErbB Receptors; Erlotinib Hydrochloride; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, erbB-1; Humans; Mouth Neoplasms; Neoplasm Proteins; Nucleic Acid Hybridization; Polymorphism, Single Nucleotide; Prognosis; Protein Kinase Inhibitors; Quinazolines; Risk Factors; Smoking; Stilbenes; Structure-Activity Relationship | 2007 |
3 other study(ies) available for erlotinib hydrochloride and Abnormalities, Autosome
| Article | Year |
|---|---|
Loss of an EGFR-amplified chromosome 7 as a novel mechanism of acquired resistance to EGFR-TKIs in EGFR-mutated NSCLC cells.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Chromosome Aberrations; Chromosomes, Human, Pair 7; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Gene Amplification; Humans; Lung Neoplasms; Mutation; Quinazolines | 2014 |
Genomic aberrations associated with erlotinib resistance in non-small cell lung cancer cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Cell Line, Tumor; Chromosome Aberrations; Drug Resistance, Neoplasm; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Quinazolines; Real-Time Polymerase Chain Reaction | 2013 |
PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activation of Akt and EGFR.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Chromosome Aberrations; Cluster Analysis; Drug Resistance, Neoplasm; Enzyme Activation; ErbB Receptors; Erlotinib Hydrochloride; Gene Deletion; Gene Expression; Humans; Lung Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Quinazolines | 2009 |